Aigen Investment Management LP Invests $539,000 in Maximus, Inc. (NYSE:MMS)

Aigen Investment Management LP acquired a new position in Maximus, Inc. (NYSE:MMS) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 7,215 shares of the health services provider’s stock, valued at approximately $539,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Charles Schwab Investment Management Inc. raised its position in shares of Maximus by 7.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider’s stock valued at $74,700,000 after buying an additional 71,598 shares in the last quarter. QRG Capital Management Inc. increased its stake in Maximus by 15.2% in the fourth quarter. QRG Capital Management Inc. now owns 4,993 shares of the health services provider’s stock valued at $373,000 after acquiring an additional 657 shares during the last quarter. Versor Investments LP raised its position in Maximus by 12.9% during the fourth quarter. Versor Investments LP now owns 9,600 shares of the health services provider’s stock valued at $717,000 after purchasing an additional 1,100 shares in the last quarter. Bryn Mawr Capital Management LLC lifted its stake in Maximus by 129.8% during the fourth quarter. Bryn Mawr Capital Management LLC now owns 4,946 shares of the health services provider’s stock worth $369,000 after purchasing an additional 2,794 shares during the last quarter. Finally, Illinois Municipal Retirement Fund boosted its holdings in shares of Maximus by 35.4% in the 4th quarter. Illinois Municipal Retirement Fund now owns 25,273 shares of the health services provider’s stock worth $1,887,000 after purchasing an additional 6,606 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Stock Performance

NYSE MMS opened at $71.26 on Friday. The company has a 50-day simple moving average of $72.80 and a two-hundred day simple moving average of $80.41. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The firm has a market cap of $4.03 billion, a price-to-earnings ratio of 15.33 and a beta of 0.71. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.68%. The ex-dividend date was Friday, February 14th. Maximus’s payout ratio is 25.81%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the company. StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a research note on Thursday, January 2nd.

Insider Activity at Maximus

In other news, Director Raymond B. Ruddy acquired 3,490 shares of the firm’s stock in a transaction on Thursday, December 12th. The shares were purchased at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the transaction, the director now owns 112,520 shares of the company’s stock, valued at $8,040,679.20. The trade was a 3.20 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Bruce Caswell bought 3,500 shares of the company’s stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average price of $70.64 per share, with a total value of $247,240.00. Following the completion of the acquisition, the chief executive officer now owns 275,929 shares of the company’s stock, valued at $19,491,624.56. This trade represents a 1.28 % increase in their position. The disclosure for this purchase can be found here. Insiders bought 7,008 shares of company stock worth $497,835 in the last three months. 1.60% of the stock is owned by insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.